Short interest in Prelude Therapeutics Inc (NASDAQ:PRLD) decreased during the last reporting period, falling from 2.94M to 2.90M. This put 16.71% of the company's publicly available shares short.

Short interest for Prelude Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Prelude Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 365.20K shares traded per day, it would take 7.93 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.